AXIM BIOTECHNOLOGIES, INC. Quarterly Nonoperating Income (Expense) in USD from Q2 2014 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Axim Biotechnologies, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2014 to Q1 2022.
  • Axim Biotechnologies, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2022 was $954K.
  • Axim Biotechnologies, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2022 was $3.01M, a 98.9% increase year-over-year.
  • Axim Biotechnologies, Inc. annual Nonoperating Income (Expense) for 2021 was $2.05M, a 52.8% increase from 2020.
  • Axim Biotechnologies, Inc. annual Nonoperating Income (Expense) for 2020 was $1.34M, a 845% increase from 2019.
  • Axim Biotechnologies, Inc. annual Nonoperating Income (Expense) for 2019 was $142K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $3.01M $954K +$962K Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-23
Q4 2021 $2.05M $3.69M +$2.97M +415% Oct 1, 2021 Dec 31, 2021 10-K/A 2022-04-19
Q3 2021 -$925K $13.2K -$980K -98.7% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-22
Q2 2021 $55.2K -$1.65M -$1.46M -781% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-23
Q1 2021 $1.51M -$8.1K +$173K +95.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 $1.34M $716K +$886K Oct 1, 2020 Dec 31, 2020 10-K/A 2022-04-19
Q3 2020 $456K $993K +$678K +215% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 -$222K -$187K -$232K -512% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
Q1 2020 $10.2K -$181K -$132K -269% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-06-02
Q4 2019 $142K -$169K +$86.3K +33.8% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-26
Q3 2019 $55.6K $315K +$713K Jul 1, 2019 Sep 30, 2019 10-Q/A 2020-11-27
Q2 2019 -$657K $45.4K +$383K Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-08-18
Q1 2019 -$1.04M -$49K +$678K +93.3% Jan 1, 2019 Mar 31, 2019 10-Q/A 2020-07-02
Q4 2018 -$1.72M -$256K +$131K +33.9% Oct 1, 2018 Dec 31, 2018 10-K/A 2020-05-20
Q3 2018 -$1.85M -$398K +$58.8K +12.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$1.91M -$338K -$210K -165% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$1.7M -$727K -$679K -1420% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$1.02M -$387K +$2.84M +88% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-08
Q3 2017 -$3.86M -$457K -$229K -100% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$3.63M -$127K -$1.52M -109% Apr 1, 2017 Jun 30, 2017 10-Q/A 2018-08-17
Q1 2017 -$2.11M -$47.8K -$59.8K -501% Jan 1, 2017 Mar 31, 2017 10-Q/A 2018-05-18
Q4 2016 -$2.05M -$3.23M -$3.06M -1743% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 $1.01M -$228K -$240K -1939% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 $1.25M $1.4M +$1.21M +643% Apr 1, 2016 Jun 30, 2016 10-Q/A 2017-09-14
Q1 2016 $37K $11.9K -$6.21K -34.2% Jan 1, 2016 Mar 31, 2016 10-Q/A 2016-05-26
Q4 2015 $43.2K -$175K Oct 1, 2015 Dec 31, 2015 10-K/A 2017-09-14
Q3 2015 $12.4K +$1.6K +14.8% Jul 1, 2015 Sep 30, 2015 10-Q/A 2016-11-30
Q2 2015 $188K +$188K Apr 1, 2015 Jun 30, 2015 10-Q/A 2016-08-25
Q1 2015 $18.1K Jan 1, 2015 Mar 31, 2015 10-Q/A 2016-05-26
Q3 2014 $10.8K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-23
Q2 2014 $0 Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-08-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.